A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH)
Clinical trial NCT05064397 · COMPLETED
Trial details
- NCT number
- NCT05064397
- Sponsor
- H. Lundbeck A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-17
- Primary completion
- 2023-06-29
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.